cover image - Rang & Dale's Pharmacology Elsevier E-Book on VitalSource, 10th Edition
ISBN: 9780443108648
Copyright: 2024
Publication Date: 08-16-2023
Page Count: 872
Imprint: Elsevier
List Price: $66.99

Rang & Dale's Pharmacology Elsevier E-Book on VitalSource, 10th Edition

by James M. Ritter, DPhil FRCP FBPhS FMedSci, Rod J. Flower, PhD DSc FBPhS FMedSci FRS, Graeme Henderson, BSc PhD FBPhS FSB, Yoon Kong Loke, MB, BS, MRCP, MD, David MacEwan, PhD, FRSB, FBPhS, SFHEA, Emma Robinson, PhD, FBPhS and James Fullerton, MA, MBChB, MRCP, PhD, FHEA.

Elsevier eBook on VitalSource

cover image - Rang & Dale's Pharmacology Elsevier E-Book on VitalSource, 10th Edition
ISBN: 9780443108648
Copyright: 2024
Publication Date: 08-16-2023
Page Count: 872
Imprint: Elsevier
List Price: $66.99
Was $66.99

Now $58.95

Or $0.00 with a valid access code

Rang and Dale’s Pharmacology is internationally acknowledged as the core textbook for students of pharmacology, and has provided accessible, up-to-date information on drugs and their mechanism of action for more than 30 years.

Now in its tenth edition, it has been updated to include important new drugs such as gene therapies, personalised medicines and the new wave of RNA drugs. However it has not lost any of the elements that have contributed to its popularity, such as color coding and illustrations, making it reader-friendly while comprehensively covering the depth of detail required.

This essential book is recommended as the first-choice undergraduate text for science and medical students and junior doctors and will also be useful for students in other professional disciplines such as pharmacy, veterinary medicine and nursing.

    • Comprehensive information on drug mechanisms, basic physiology and biochemistry, and underlying pathophysiology of disease – suitable for students from many disciplines
    • Clear figures to aid understanding, including data figures as well as mechanistic diagrams,
    • Key points box summaries, clinical boxes and colour-coded chapters help to master difficult concepts
    • Emphasis on therapeutic drugs to help apply theory to practice
    • Over 150 questions and 12 clinical cases to test your knowledge
    • An enhanced eBook version is included with purchase. The eBook allows you to access all the text, figures and references, with the ability to search, customise your content, make notes and highlights, and have content read aloud
  • SECTION 1 GENERAL PRINCIPLES
    1. What is pharmacology?
    2. How drugs act: general principles
    3. How drugs act: molecular aspects
    4. How drugs act: cellular aspects - excitation, contraction and secretion
    5. How drugs act: Biopharmaceuticals and gene therapy
    6. Cell proliferation, apoptosis, repair and regeneration
    7. Cellular mechanisms: host defence
    8. Method and measurement in pharmacology
    9. Absorption and distribution of drugs
    10. Drug metabolism and elimination
    11. Pharmacokinetics
    12. Individual variation, pharmacogenomics and personalised medicine

    SECTION 2 CHEMICAL MEDIATORS
    13. Chemical mediators and the autonomic nervous system
    14. Cholinergic transmission
    15. Noradrenergic transmission
    16. 5-Hydroxytryptamine and purines
    17. Local hormones: histamine, lipids, peptides and proteins
    18. Cannabinoids
    19. Nitric oxide and related mediators

    SECTION 3 DRUGS AFFECTING MAJOR ORGAN SYSTEMS
    20. The heart
    21. The vascular system
    22. Atherosclerosis and lipoprotein metabolism
    23. Haemostasis and thrombosis
    24. Haemopoietic system and treatment of anaemia
    25. Anti-inflammatory and immunosuppressant drugs
    26. Skin
    27. Eye
    28. Respiratory system
    29. The kidney and urinary system
    30. The gastrointestinal tract
    31. The control of blood glucose and drug treatment of diabetes mellitus
    32. Obesity
    33. The pituitary and the adrenal cortex
    34. Thyroid
    35. The reproductive system
    36. Bone metabolism

    SECTION 4 NERVOUS SYSTEM
    37. Chemical transmission and drug action in the central nervous system
    38. Amino acid transmitters
    39. Other transmitters and modulators
    40. Neurodegenerative diseases
    41. General anaesthetic agents
    42. Headache
    43. Analgesic drugs
    44. Local anaesthetics and other drugs affecting sodium channels
    45. Anxiolytic and hypnotic drugs
    46. Antiepileptic drugs
    47. Antipsychotic drugs
    48. Antidepressant drugs
    49. Psychoactive drugs
    50. Drug use and addiction

    SECTION 5 DRUGS USED FOR THE TREATMENT OF INFECTIONS AND CANCER
    51. Basic principles of antimicrobial chemotherapy
    52. Antibacterial drugs
    53. Antiviral drugs
    54. Antifungal drugs
    55. Antiprotozoal drugs
    56. Antihelminthic drugs
    57. Anticancer drugs

    SECTION 6 SPECIAL TOPICS
    58. Harmful effects of drugs
    59. Lifestyle drugs and drugs in sport
    60. Drug discovery and development
  • James M. Ritter, DPhil FRCP FBPhS FMedSci, Emeritus Professor of Clinical Pharmacology, King’s College London, and Medical Research Director, Quintiles, London, UK, Rod J. Flower, PhD DSc FBPhS FMedSci FRS, Professor, Biochemical Pharmacology, The William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London , London, UK, Graeme Henderson, BSc PhD FBPhS FSB, Professor of Pharmacology, University of Bristol, Bristol, UK, Yoon Kong Loke, MB, BS, MRCP, MD, Senior Lecturer in Clinical Pharmacology, School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, UK, David MacEwan, PhD, FRSB, FBPhS, SFHEA, Professor of Molecular Pharmacology/Toxicology & Head of Department, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK, Emma Robinson, PhD, FBPhS, Professor of Psychopharmacology, University of Bristol, Bristol, UK and James Fullerton, MA, MBChB, MRCP, PhD, FHEA., Associate Professor of Clinical Therapeutics and Honorary Consultant in Acute General Medicine and Clinical Pharmacology, University of Oxford, Oxford, UK
    • Ways of Reading
      • The appearance of the text and page layout can be modified according to the capabilities of the reading system (font family and font size, spaces between paragraphs, sentences, words, and letters, as well as color of background and text)
      • This e-publication is accessible to the full extent that the file format and types of content allow, on a specific reading device, by default, without necessarily including any additions such as textual descriptions of images or enhanced navigation
      • No information about nonvisual reading is available
    • Conformance
      • No information is available
    • Navigation
      • Table of contents to all chapters of the text via links
      • Page list to go to pages from the print source version
    • Rich Content
      • No information is available
    • Hazards
      • No information is available
    • Product Content
      • No information is available
    • Legal Considerations
      • No information is available
    • Additional Accessibility Information
      • Content is enhanced with ARIA roles to optimize organization and facilitate navigation
      • Page breaks included from the original print source
      • For readers with color vision deficiency, use of color (e.g., in diagrams, graphics and charts, in prompts, or on buttons inviting a response) is not the sole means of graphical distinction or of conveying information
      • E-publication includes basic navigation (usually less detailed than TOC-based navigation)
      • Where links, controls or buttons are included in the content, the purpose or functionality of each link, control or button is apparent from the associated text alone - or where it is unclear, separate link, control or button descriptions are provided
      • All (or substantially all) textual matter is arranged in a single logical reading order (including text that is visually presented as separate from the main text flow, e.g., in boxouts, captions, tables, footnotes, endnotes, citations, etc.). Non-textual content is also linked from within this logical reading order. (Purely decorative non-text content can be ignored).
      • The language of the text has been specified (e.g., via the HTML or XML lang attribute) to optimise text-to-speech (and other alternative renderings), both at the whole document level and, where appropriate, for individual words, phrases or passages in a different language.
Was $66.99

Now $58.95

Or $0.00 with a valid access code